Skip to main content

Study M565

Study name

Yang Q 2020

Title

Chronic minocycline treatment exerts antidepressant effect, inhibits neuroinflammation, and modulates gut microbiota in mice

Overall design

The aim of this study was to detect the effects of chronic minocycline treatment on antidepression, neuroinflammation, and gut microbiota modulation in the chronic unpredictable mild stress (CUMS) mouse model of depression. C57BL/6 mice were divided into the following 3 groups: (1) control group, (2) CUMS group, and (3) CUMS + minocycline group (stressor plus minocycline treatment at the dose of 40 mg/kg). The CUMS stress procedure lasted for 6 weeks, and minocycline was administered intraperitoneally once per day during the last 4 weeks of model building period. The cecum and proximal colons were collected for gas chromatography mass spectrometry-based metabonomic analysis.

Study Type

Type1;

Type2;

Data available

Unavailable

Organism

Mouse; C57BL/6 mouse;

Categories of depression

Animal model; Chronic mild stress model; Chronic mild stress model;

Criteria for depression

Forced swimming test, tail suspension test

Sample size

22

Tissue

Peripheral; Gut; Intestine;

Platform

MS-based; GC-MS: Agilent 7890A with Agilent 5975C MSD;

PMID

32671421

DOI

10.1007/s00213-020-05604-x

Citation

Yang Q, Luo L, Sun T, et al. Chronic minocycline treatment exerts antidepressant effect, inhibits neuroinflammation, and modulates gut microbiota in mice. Psychopharmacology. 2020 Oct;237(10):3201-3213.

Metabolite

Phosphoric acid;

Sarcosine;

Butyric acid;

2-aminoisobutanoic acid;

5-(2-Hydroxyethyl)-4-methylthiazole;